G. LECLERC
- Organic Chemistry top 10%
- Synthesis of heterocyclic compounds 9
- Synthesis and biological activity 8
- Organic Chemistry Cycloaddition Reactions 6
- Synthesis and Biological Evaluation 4
-
- Eicosanoids and Hypertension Pharmacology 4
- Animal Science and Zoology top 10%
- Pharmacological Effects and Assays 5
-
- Chemical Synthesis and Analysis 5
-
- Analytical Methods in Pharmaceuticals 4
G. LECLERC
40 papers receiving 464 citations
Peers
Comparison fields: 5 of 78
- Organic Chemistry 239
- Cellular and Molecular Neuroscience 93
- Biochemistry 35
- Animal Science and Zoology 40
- Physiology 82
Countries citing papers authored by G. LECLERC
This map shows the geographic impact of G. LECLERC's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. LECLERC with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. LECLERC more than expected).
Fields of papers citing papers by G. LECLERC
This network shows the impact of papers produced by G. LECLERC. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. LECLERC. The network helps show where G. LECLERC may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G. LECLERC, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2003 | 1 | |
| 3 | Synthesis and bovine beta-3 adrenergic agonistic activities of a novel series of aryloxypropanolamines. | 2001 | 0 |
| 4 | 1998 | 2 | |
| 5 | 1996 | 18 | |
| 6 | 1994 | 3 | |
| 7 | 1994 | 7 | |
| 8 | 1992 | 14 | |
| 9 | 1992 | 22 | |
| 10 | 1991 | 7 | |
| 11 | 1987 | 6 | |
| 12 | 1986 | 0 | |
| 13 | 1986 | 3 | |
| 14 | In vitro potential measurement, anaesthetic and antimicrobial effects as indicators of beta-blocker toxicity of the cornea. | 1985 | 5 |
| 15 | Derivatives related to betaxolol with alpha- and beta-adrenergic activities. | 1985 | 1 |
| 16 | 1984 | 1 | |
| 17 | 1980 | 2 | |
| 18 | 1979 | 2 | |
| 19 | [Pharmacological study of para-aminoclonidine, an alpha sympathomimetic]. | 1978 | 1 |
| 20 | 1977 | 79 |
About G. LECLERC
G. LECLERC is a scholar working on Organic Chemistry, Biochemistry, Animal Science and Zoology, Analytical Chemistry and Biological Psychiatry, having authored 46 papers that have together received 500 indexed citations. Recurring topics across this work include Synthesis of heterocyclic compounds (9 papers), Synthesis and biological activity (8 papers), Organic Chemistry Cycloaddition Reactions (6 papers), Pharmacological Effects and Assays (5 papers), Chemical Synthesis and Analysis (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Analytical Methods in Pharmaceuticals (4 papers) and Synthesis and Biological Evaluation (4 papers). The work is most often cited by research in Organic Chemistry (239 citations), Cellular and Molecular Neuroscience (93 citations), Biochemistry (35 citations), Animal Science and Zoology (40 citations) and Physiology (82 citations). G. LECLERC has collaborated with scholars based in France, Canada and Morocco. Frequent co-authors include J. Schwartz, J Velly, Camille G. Wermuth, B. Rouot, Nicole Decker, J.C. Schwartz, Jean‐Louis Imbs, A Boucherle, D. H. R. BARTON and Philip Magnus. Their work appears in journals such as European Journal of Medicinal Chemistry, Tetrahedron Letters, British Journal of Pharmacology, Stem Cells and Naunyn-Schmiedeberg s Archives of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.